← The deskPharmacology & mechanisms
Priya Anand
How these molecules actually work — and where the mechanism story outruns the human data.
Priya Anand is a pen name used by a writer at Aminoscope, published by MEAS Partners, LLC. Priya writes about pharmacology and molecular mechanisms: receptor binding, half-life profiles, drug-drug interactions, and the critical line between a plausible mechanism and demonstrated clinical effect.
What they cover
- GLP-1 and GIP receptor pharmacology
- Peptide half-life and pharmacokinetics
- Drug-drug interactions
- Receptor binding and downstream signaling
- Mechanism-vs-evidence evaluation
- Peptide chemistry and stability
Articles by Priya Anand
106 pieces- Retatrutide side effects: what the Phase 2 trials actually reportedGLP-1
- TUDCA side effects: generally well tolerated, with real limitsLongevity
- Ipamorelin side effects: mild on paper, thin on data, and a gray-market catchPeptides
- CJC-1295 side effects: what's measured, what's inferred, and the DAC concernPeptides
- Rapamycin side effects: the approved-use profile and the longevity-dose nuanceLongevity
- Urolithin A side effects: a clean record, but short trialsLongevity
- Spermidine side effects: well tolerated, and one theoretical caveatLongevity
- Fisetin side effects: well tolerated, with honest cautionsLongevity
- Cerebrolysin side effects: well tolerated, with one serious flagLongevity
- Glutathione side effects: oral is benign, injectable skin-whitening is notLongevity
- SS-31 (elamipretide) dosage: what the trials actually usedLongevity
- Cerebrolysin dosage: the regimens trials actually usedLongevity
- Orforglipron dosage: the doses studied, and what the label actually coversGLP-1
- Spermidine dosage: the trials used about 1 mg a dayLongevity
- Urolithin A dosage: the doses the trials actually usedLongevity
- Fisetin dosage: the “hit-and-run” trial protocol vs the supplement bottleLongevity
- Retatrutide dosage: the doses studied, and why there is no approved oneGLP-1
- “Microdosing” GLP-1 drugs: a trend, not a protocol — what the dose-response evidence actually saysGLP-1
- Oral tirzepatide: the honest status of a pill that does not exist yetGLP-1
- The best berberine supplement: an evidence-first buyer’s guideLongevity
- Semaglutide and GLP-1s for PCOS: what the evidence actually showsGLP-1
- Peptides for anxiety: Selank, Semax and DSIP graded by real human evidencePeptides
- Gonadorelin vs hCG: Testosterone, Fertility, and Libido on TRTLongevity
- Do Growth Hormone Peptides Affect Libido? Sermorelin, Ipamorelin, MK-677 and the EvidencePeptides
- Enclomiphene, Libido, and Erectile Function: What to ExpectLongevity
- Ozempic, Libido, and Erectile Dysfunction: What the Evidence ShowsGLP-1
- Melanotan II and Libido: The Erection Side Effect That Became a DrugPeptides
- Kisspeptin and Libido: What the Brain-Imaging Trials Actually FoundPeptides
- Apomorphine for ED: How It Works and What the Evidence ShowsLongevity
- How to Increase Deep Sleep: What the Evidence Actually ShowsPeptides
- Growth Hormone Secretagogues: GHRH Analogs vs GHRPs ExplainedPeptides
- TB-500 dosage: why there isn't an approved onePeptides
- GHK-Cu dosage: topical concentrations versus the unvalidated injectionPeptides
- PT-141 (bremelanotide) dosage: the one approved dose, and how community use departs from itPeptides
- Semax dosage: the intranasal doses studied — and why none are FDA-approvedPeptides
- MOTS-c dosage: there is no validated human doseLongevity
- Melanotan II dosage: there is no safe dose, and here’s whyPeptides
- IGF-1 LR3 dosage: there is no validated human dose — and why that mattersPeptides
- Dihexa dosage: why there is no established human dosePeptides
- DSIP dosage: why there is no validated protocolPeptides
- KPV dosage: why there is no established human dosePeptides
- Thymosin alpha-1 dosage: the 1.6 mg twice-weekly trial regimen, in contextPeptides
- Hexarelin dosage: the studied doses, and why there's no safe standing protocolPeptides
- HGH Fragment 176-191 dosage: why there's no validated dose to givePeptides
- 5-Amino-1MQ dosage: why there is no validated human dosePeptides
- Kisspeptin dosage: research infusions, not a home-injection protocolPeptides
- Humanin dosage: why there is no validated human doseLongevity
- TB-500 side effects: why “none reported” means “none studied”Peptides
- GHK-Cu side effects: why route is the whole storyPeptides
- PT-141 (bremelanotide) side effects: trial-grade data led by nausea, plus a blood-pressure flagPeptides
- Semax side effects: a quiet record, and a much larger unknownPeptides
- MOTS-c side effects: the human safety data simply doesn't existLongevity
- Melanotan II side effects: the mole problem, priapism and serious rare eventsPeptides
- IGF-1 LR3 side effects: hypoglycemia, overgrowth, and the cancer concernPeptides
- Hexarelin side effects: the cortisol, prolactin and desensitization problemsPeptides
- Dihexa side effects: unknown in humans, not proven safePeptides
- DSIP side effects: a thin old record, no modern safety datasetPeptides
- KPV side effects: why “no reported side effects” isn’t reassurancePeptides
- Thymosin alpha-1 side effects: real trial data, read against the online vialPeptides
- Cagrilintide dosage: what the trials used, and why there's no approved doseGLP-1
- Cagrilintide side effects: a gastrointestinal, titration-shaped profileGLP-1
- Gonadorelin: real GnRH with a proven pump role — and an unproven TRT-adjunct pitchLongevity
- Peptides vs SARMs: a structural class versus a single drug classPeptides
- Ipamorelin vs HGH: the hormone, or a request for the hormone?Peptides
- MK-677 vs HGH: can an oral pill replace injectable growth hormone?Peptides
- Hexarelin vs ipamorelin: stronger but dirtier vs cleaner but milderPeptides
- BPC-157 vs TB-500: the recovery peptide pair, graded on evidencePeptides
- Anastrozole for Men: Does Blocking Estrogen Actually Help?Longevity
- Paraxanthine: The Evidence on Caffeine's Primary MetaboliteLongevity
- How to Inject Peptides Subcutaneously: A Careful, Evidence-Based WalkthroughPeptides
- How to Cycle Peptides: What the Pharmacology Actually SupportsPeptides
- AOD-9604 dosage: what's used, and why the number is borrowedPeptides
- Ipamorelin vs sermorelin: two receptors, one growth-hormone pulsePeptides
- Tesamorelin vs ipamorelin: an approved drug versus a research peptidePeptides
- CJC-1295 & ipamorelin dosage: the circulated numbers vs. what's actually provenPeptides
- How to reconstitute peptides: the process, the math, and the honest caveatPeptides
- Ipamorelin dosage: the microgram numbers people circulate vs. what's actually provenPeptides
- Thymosin alpha-1 (Tα1): a real immune drug abroad, read against the wellness pitchPeptides
- Hexarelin: a potent GH peptide — with cortisol, prolactin and desensitization in the fine printPeptides
- Melanotan 1 vs Melanotan 2: an approved drug versus a gray-market injectablePeptides
- Selank dosage: the honest answer to “how much” for an unapproved peptidePeptides
- Epitalon (epithalon) dosage: the circulated short-course schedule vs. the (missing) standardLongevity
- Contrave side effects: nausea, the serious warnings, and the honest safety pictureGLP-1
- GLP-1 and hair loss: is it the drug, or the weight loss?GLP-1
- Alcohol and Ozempic: does a GLP-1 really make you drink less?GLP-1
- 'Ozempic face': what it is, and what it isn'tGLP-1
- How to get Ozempic in 2026: the honest pathwayGLP-1
- How to get Mounjaro in 2026: the honest pathwayGLP-1
- Tesamorelin (Egrifta): what it's actually FDA-approved for, and the evidencePeptides
- BPC-157 dosage and safety: why there is no validated human dosePeptides
- BPC-157 side effects and safety: what the thin human evidence actually showsPeptides
- Sermorelin dosage: the clinical history vs. the modern anti-aging claimPeptides
- Tesamorelin dosage: the FDA-approved 2 mg dose vs. the off-label frontierPeptides
- Tesamorelin (Egrifta) side effects: the documented, label-monitored profilePeptides
- PT-141 (bremelanotide): the evidence on a research-popular peptide that is actually FDA-approvedPeptides
- Enclomiphene: the evidence for restoring testosterone without replacing itLongevity
- Enclomiphene vs TRT: same testosterone, opposite effect on fertilityLongevity
- Enclomiphene dosage: what the trials actually usedLongevity
- Enclomiphene side effects: what the trials actually foundLongevity
- MK-677 dosage: what the trials actually usedPeptides
- MK-677 side effects: the blood-sugar problem and a cardiac flagPeptides
- Berberine dosage: how much, when, and the safety catchesLongevity
- TRT: what testosterone therapy is actually proven to doLongevity
- TRT side effects: the real risks, and the monitoring that manages themLongevity
- TRT vs natural testosterone: what actually works?Longevity
- Low testosterone treatment: the stepwise options that actually workLongevity